434 related articles for article (PubMed ID: 31646568)
1. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
2. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.
Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH
Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer.
Huang HG; Tang XL; Huang XS; Zhou L; Hao YG; Zheng YF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4232-4245. PubMed ID: 32373959
[TBL] [Abstract][Full Text] [Related]
6. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
Zhang X; Zhang X; Yu B; Hu R; Hao L
Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
[TBL] [Abstract][Full Text] [Related]
7. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
Gong A; Huang Z; Ge H; Cai Y; Yang C
J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
[TBL] [Abstract][Full Text] [Related]
8. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
Fang J; Sun CC; Gong C
Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
[TBL] [Abstract][Full Text] [Related]
10. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.
Liu JQ; Feng YH; Zeng S; Zhong MZ
Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854
[TBL] [Abstract][Full Text] [Related]
11. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
[TBL] [Abstract][Full Text] [Related]
12. LINC01232 Promotes Gastric Cancer Proliferation through Interacting with EZH2 to Inhibit the Transcription of KLF2.
Liu J; Li Z; Yu G; Wang T; Qu G; Wang Y
J Microbiol Biotechnol; 2021 Oct; 31(10):1358-1365. PubMed ID: 34409953
[TBL] [Abstract][Full Text] [Related]
13. The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade promotes malignant and metastatic progression of osteosarcoma.
Liu K; Ni JD; Li WZ; Pan BQ; Yang YT; Xia Q; Huang J
Mol Oncol; 2020 Oct; 14(10):2678-2695. PubMed ID: 32634265
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer.
Huang M; Hou J; Wang Y; Xie M; Wei C; Nie F; Wang Z; Sun M
Mol Ther; 2017 Apr; 25(4):1014-1026. PubMed ID: 28214253
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer.
Lian Y; Wang J; Feng J; Ding J; Ma Z; Li J; Peng P; De W; Wang K
Tumour Biol; 2016 Nov; 37(11):14929-14937. PubMed ID: 27644252
[TBL] [Abstract][Full Text] [Related]
17. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
18. IncRNA Linc00511 Upregulation Elevates TGFBR1 and Participates in the Postoperative Distant Recurrence of Non-Small-Cell Lung Cancer by Targeting miR-98-5p.
Li C; Li Z; Yi H; Liu Z
Crit Rev Eukaryot Gene Expr; 2022; 32(5):1-10. PubMed ID: 35993940
[TBL] [Abstract][Full Text] [Related]
19. lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell Lung Carcinoma via Suppressing PTEN Level.
Chen X; Wang K
Med Sci Monit; 2019 Nov; 25():8363-8370. PubMed ID: 31695021
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription.
Min J; Ma J; Wang Q; Yu D
Clinics (Sao Paulo); 2022; 77():100081. PubMed ID: 36087568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]